Evozyne
Generative AI-powered drug discovery platform and product development
54 employees · est. 2020 · Chicago, United States
SilicoGenesis
Develop better antibodies faster with our AI-enabled in silico antibody engineering platform.
4 employees · est. 2021 · Leuven, Belgium
Evozyne is the older company (2020 vs 2021); Evozyne is the larger of the two.
Side-by-Side Comparison
| Metric | Evozyne | SilicoGenesis |
|---|---|---|
| Founded | ||
| Founded | 2020 older | 2021 |
| Headquarters | ||
| Headquarters | Chicago, United States | Leuven, Belgium |
| Employees | ||
| Employees | 54 larger | 4 |
| Industry | ||
| Industry | Biotechnology, Pharmaceutical | Biotechnology |
| Funding Stage | ||
| Funding Stage | Series B | Not tracked yet |
| Total Funding | ||
| Total Funding | $144.36M | Not tracked yet |
| Funding Rounds | ||
| Funding Rounds | 4 | Not tracked yet |
| Services | ||
| Services | AI-native Protein Design, Protein Synthesis and Testing, Therapeutic Protein Development, Immunology Pipeline Advancement | Not tracked yet |
| Target Customers | ||
| Target Customers | Patients with High Unmet Need in Immune-Mediated Diseases, Healthcare Providers, Pharmaceutical Companies | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Generative AI, Drug Discovery, Protein Design, Therapeutic Discovery, Molecular Scale, Novel Protein Therapeutics, Healthcare Innovation, AI In Drug Development, Complex Challenges, Protein Engineering, Societal Challenges Solution | Antibody Engineering, Biotechnology Research, Bioinformatics, Computational Biology, Protein Biochemistry, Structural Biology, Drug Discovery, Protein Engineering |
| Website | ||
| Website | evozyne.com | silicogenesis.com |
About Evozyne
Evozyne, founded in 2020, is at the forefront of the Biotechnology and Pharmaceutical industries with its innovative approach to drug development. The company's slogan, "Generative AI-powered drug discovery platform and product development," encapsulates its mission to design novel protein therapeut...
About SilicoGenesis
SilicoGenesis is a biotechnology startup headquartered in Belgium, founded in 2021. The company specializes in revolutionizing the field of antibody and biologic design, discovery, and optimization through its AI-enabled in silico antibody engineering platform. SilicoGenesis offers a comprehensive s...
We will tell you when either one moves
BounceWatch watches Evozyne and SilicoGenesis for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Evozyne and SilicoGenesis — by email.
Frequently Asked Questions
Compare Evozyne with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Evozyne on 15 Jun 2026, and SilicoGenesis on 21 Jun 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
